"Rising Concerns: Fake Ozempic Linked to Life-Threatening Hypoglycemia Cases in the US"

Three cases of hypoglycemia in the US were linked to suspected fake versions of Novo Nordisk's diabetes drug Ozempic, with one case involving a compounded version. Explosive demand for Ozempic and similar drugs for weight loss has fueled a global market for counterfeit versions. Austrian and Lebanese health authorities also reported cases of hypoglycemia linked to suspected fake Ozempic. The FDA is investigating these cases, and Novo Nordisk reported finding some samples of compounded semaglutide to be impure.